UK-CAB 11 – Community participation in preventive HIV vaccine trials

14 November 2004

Programme
PowerPoint slides for the meeting

Programme

13.55 Welcome
14.00 The Need for Community Involvement – Ken Legg, Imperial College of London, London, UK
14.10 Lessons from Participating in a vaccine trial – Jo Robinson, UK CAB/EATG Vaccines Working Group, London, UK
14.20 Community Participation in Western Europe – Emmanuel Trénado, EATG Vaccines Working Group, Paris, France
14.30 Community Participation in Eastern Europe – Dmitry Samoylov, Community of People Living with HIV/AIDS, Moscow, Russian Federation
14.40 European AIDS Vaccine Trials: Advocacy Agenda – Marion Zibelli, EATG Vaccines Working Group, Barcelona, Spain
14.45 Discussion
15.00 Ends

Link to top of page

Approaches to Community Participation in Preventive HIV Vaccine

During the 7th International Conference on HIV and Drug Therapy in Glasgow, November 14-18 2004, the Vaccine Working Group of the EATG and the UK-CAB held a workshop on ‘Approaches to Community Participation in Preventive HIV Vaccine Trials” [all presentations are available for download]

The workshop provided an introduction to the need for community development and participation in this area of research, by demostrating approaches taken to identify, reach, recruit and maintain communities for the conduct of clinical trials in European countries, Eastern Europe and Central Asia. More than 50 advocates from all over the world discussed future strategies for improving community participation and lobbying actions at the national and European level.
Link to top of page

PowerPoint slides for the meeting

The Need for Community Involvement
Ken Legg,
Imperial College of London, London, UK
[download the presentation] [448k]

Lessons from Participating in a vaccine trial
Jo Robinson
, UK CAB/EATG Vaccines Working Group, London, UK
[download the presentation] [212k]

Community Participation in Western Europe
Emmanuel Trénado
, EATG Vaccines Working Group, Paris, France
[download the presentation] [2.1MB]

Community Participation in Eastern Europe
Dmitry Samoylov,
Community of People Living with HIV/AIDS, Moscow, Russian Federation
[download the presentation] [1.4MB]

European AIDS Vaccine Trials: Advocacy Agenda
Marion Zibelli,
EATG Vaccines Working Group, Barcelona, Spain
[download the presentation] [148k]

The UK CAB and EATG thanks the organizers of the 7th International Conference on HIV and Drug Therapy for their kind support in preparing the workshop.

Financial support

The UK-CAB receives unrestricted funding from some pharmaceutical companies towards the direct costs of holding four meetings each year. This funding supports the travel and accommodation costs for members to attend from outside London, plus the cost of catering.

The content, programme and agenda for meetings is decided by the UK-CAB steering group in consultation with the wider membership. Funding is unconnected to meeting content.

We believe that manufacturers who currently develop and market medicines have a responsibility to actively engage with advocacy organisations and that HIV positive people and their advocates should be able to directly question manufacturers about the safety and efficacy of their products and proposals for future research.

For a list of companies that support the UK-CAB please see the “about us” page.

Link to top of page

Edit
Published: November 14, 2004
Last edited: August 15, 2013